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e used chemical genetics to control the activity
of budding yeast Prk1p, which is a protein kinase
that is related to mammalian GAK and AAK1,
and which targets several actin regulatory proteins implicated
in endocytosis. In vivo Prk1p inhibition blocked phero-
mone receptor endocytosis, and caused cortical actin
patches to rapidly aggregate into large clumps that contained
Abp1p, Sla2p, Pan1p, Sla1p, and Ent1p. Clump formation
depended on Arp2p, suggesting that this phenotype might
result from unregulated Arp2/3-stimulated actin assembly.
Electron microscopy/immunoelectron microscopy analysis
W
 
and tracking of the endocytic membrane marker FM4-64
revealed vesicles of likely endocytic origin within the actin
clumps. Upon inhibitor washout, the actin clumps rapidly
disassembled, and properly polarized actin patches re-
appeared. Our results suggest that actin clumps result from
blockage at a normally transient step during which actin
assembly is stimulated by endocytic proteins. Thus, we
revealed tight phosphoregulation of an intrinsically dynamic,
actin patch–related process, and propose that Prk1p neg-
atively regulates the actin assembly–stimulating activity
of endocytic proteins.
 
Introduction
 
Control of actin dynamics by associated proteins plays a
crucial role in many biological processes including endocy-
tosis, exocytosis, organelle inheritance, cell motility, and cell
morphogenesis. F-actin in 
 
Saccharomyces cerevisiae
 
 is mainly
found in three distinct structures: cables, the contractile
ring, and cortical patches (Pruyne and Bretscher, 2000).
Actin patches can be highly motile (0.06–1 
 
 
 
m/s) and
undergo active turnover (for review see Engqvist-Goldstein
and Drubin, 2003). They are also functionally linked to
endocytosis, as many actin patch components are essential
for this process, and drugs that perturb actin turnover inhibit
endocytosis (for review see Engqvist-Goldstein and Drubin,
2003). Consistent with these observations, transient association
between the actin cytoskeleton and endocytic sites has recently
been shown to be a characteristic of caveolae- and clathrin-
mediated endocytosis in mammalian cells (for review see
Engqvist-Goldstein and Drubin, 2003). However, the molec-
ular mechanisms underlying actin’s involvement in endocytosis
remain poorly understood.
Yeast actin-regulating kinase (Ark) 1p and Prk1p, a redun-
dant pair of Ark family kinases, are strong candidates to directly
couple the dynamic processes of actin cytoskeleton assembly
and endocytosis (for review see Smythe and Ayscough,
2003). The three known in vivo targets of Prk1p, Pan1p
(Eps15-related Arp2/3 activator; Zeng and Cai, 1999; Duncan
et al., 2001), Ent1p (epsin-related protein; Watson et al.,
2001), and Sla1p (an adaptor for Ste2p receptor endocytosis;
Zeng and Cai, 1999; Howard et al., 2002), are actin patch
proteins. Each of these Prk1p targets plays an important role
in both endocytosis and in actin cytoskeleton regulation
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(for review see Engqvist-Goldstein and Drubin, 2003). Both
elevation and loss of Ark kinase activity lead to defective ac-
tin cytoskeleton organization and endocytosis (Cope et al.,
1999; Zeng and Cai, 1999; Watson et al., 2001; Zeng et al.,
2001), suggesting that the regulation by protein phosphory-
lation is crucial for both systems. A mammalian Ark family
kinase, AAK1, localizes to sites of clathrin-mediated endocy-
tosis, and phosphorylation by AAK1 negatively regulates en-
docytosis (Conner and Schmid, 2002).
To gain insights into the regulatory mechanisms of actin
cytoskeleton assembly and endocytosis by Prk1p, we used a
chemical genetics approach (Bishop et al., 2001) that en-
abled us to rapidly modulate Prk1p activity in vivo. In com-
parison to the conventional approach using kinase-dead mu-
tants, this approach enabled us to investigate the direct and
immediate consequence of Prk1p inactivation for the regula-
tion of actin assembly and endocytosis.
 
Results and discussion
 
Construction of 
 
prk1-
 
analogue-sensitive (
 
prk1-as
 
) 
mutants that rapidly respond to 1NA-PP1
 
To determine how Prk1p functions in actin organization
and endocytosis in living cells, we created analogue-sensitive
mutants (Bishop et al., 2001) of Prk1p in cells that lack
Ark1p. Inactivation of both kinases was necessary because ei-
ther one alone is sufficient to carry out the functions related
to actin organization (Cope et al., 1999) and endocytosis
(unpublished data). We constructed 
 
ark1
 
 
 
 
 
prk1-as1
 
 (with a
M108G mutation) and 
 
ark1
 
 
 
 
 
prk1-as3
 
 (with M108G and
C175A mutations) strains, in which substitutions of bulky
amino acids in the ATP-binding pocket of Prk1p were made
to render the kinase sensitive to a PP1 analogue, 4-amino-1-
 
tert
 
-butyl-3-(1
 
 
 
-naphthyl)pyrazolo[3,4-
 
d
 
]pyrimidine (1NA-
PP1; Bishop et al., 1998). In the absence of 1NA-PP1, both
 
ark1
 
 
 
 
 
prk1-as1
 
 and 
 
ark1
 
 
 
 
 
prk1-as3
 
 mutants had growth
rates and actin morphologies indistinguishable from the
wild-type parent strain, and showed normal growth at 37
 
 
 
C.
 
ark1
 
 
 
 
 
prk1-as1
 
 and 
 
ark1
 
 
 
 
 
prk1-as3
 
 cells showed specific
sensitivity to 1NA-PP1. Upon treatment of these mutants
with 1NA-PP1, unpolarized actin and actin clumps were ob-
served in a dose-dependent manner (Fig. 1, A and B), indi-
cating that inhibitor treatment mimics the phenotype seen
upon loss of Ark1p and Prk1p (Cope et al., 1999). Actin ca-
bles appeared to be unaffected by inhibitor addition (Fig. 1
A; 
 
 
 
1NA-PP1). As assessed by quantifying the percentage
of cells forming actin clumps, the effect of 1NA-PP1 was
saturated at 80 
 
 
 
M for 
 
ark1
 
 
 
 
 
prk1-as1
 
, and at 40 
 
 
 
M for
 
ark1
 
 
 
 
 
prk1-as3
 
 (Fig. 1 B). As a further indication that
 
ark1
 
 
 
 
 
prk1-as3
 
 cells are more sensitive to the inhibitor, at
optimal inhibitor doses, 40 
 
 
 
M for 
 
ark1
 
 
 
 
 
prk1-as3
 
 and 80
 
 
 
M for 
 
ark1
 
 
 
 
 
prk1-as1
 
, 
 
 
 
95% of 
 
ark1
 
 
 
 
 
prk1-as3
 
 cells
formed actin clumps, whereas 
 
 
 
80% of 
 
ark1
 
 
 
 
 
prk1-as1
 
 cells
formed clumps (Fig. 1 B). The actin cytoskeleton of 
 
ark1
 
 
 
PRK1
 
 cells was not affected by 40–120 
 
 
 
M 1NA-PP1 (un-
published data).
Next, we analyzed the in vivo phosphorylation of Ent1p, a
target of Prk1p that shows a Prk1p-dependent mobility shift
(Watson et al., 2001). Both 
 
ark1
 
 
 
 
 
prk1-as1
 
 and 
 
ark1
 
 
 
 
 
prk1-
 
as3
 
 cells display wild-type Ent1p phosphorylation levels in
the absence of 1NA-PP1 (Fig. 1 C). Addition of inhibitor
for 30 min resulted in a dose-dependent inhibition of Ent1p
phosphorylation in 
 
ark1
 
 
 
 
 
prk1-as1
 
 cells (Fig. 1 D, bottom).
With 80 
 
 
 
M inhibitor, Ent1p phosphorylation was severely
inhibited by 5 min, and appeared completely inhibited by
15 min (Fig. 1 E). Ent1p phosphorylation in 
 
ark1
 
 
 
 
 
PRK1
 
cells was not affected by 40–120 
 
 
 
M 1NA-PP1 (Fig. 1
D, top). Thus, 1NA-PP1 specifically and rapidly inhibits
Prk1p-as kinase activity. Next, we evaluated actin organiza-
tion as a function of time after Prk1p inhibition (Fig. 1 F).
By 2 min, 
 
 
 
60% of the 
 
ark1
 
 
 
 
 
prk1-as3
 
 cells had lost actin
patch polarization and/or had actin clumps. By 20 min, the
percentage of the cells with actin clumps reached saturation
(
 
 
 
80% for 
 
ark1
 
 
 
 
 
prk1-as1
 
, unpublished data; 
 
 
 
95% for
 
ark1
 
 
 
 
 
prk1-as3
 
, Fig. 1 F). Interestingly, at 2 min, the major-
ity of the actin clumps in 
 
ark1
 
 
 
 
 
prk1-as1
 
 and 
 
ark1
 
 
 
 
 
prk1-
as3
 
 cells were found in the daughter cell. At 5 min, actin
clumps were mainly seen in the mother cell.
The Prk1p target Pan1p is an activator of the Arp2/3
complex. By introducing the temperature-sensitive 
 
arp2-1
 
mutant of an Arp2/3 complex subunit into the 
 
ark1
 
 
 
 
 
prk1-
as3
 
 background, we tested whether Arp2/3-mediated actin
assembly is required for clump formation. The 
 
arp2-1
 
 mu-
tant shows significant endocytic defects at the permissive
temperature, although it displays normal actin organization
(Moreau et al., 1997). The 
 
ark1
 
 
 
 
 
prk1-as3
 
 
 
arp2-1
 
 cells
formed actin clumps much less efficiently (
 
 
 
5%, 
 
n
 
 
 
  
 
100)
than 
 
ark1
 
  prk1-as3 cells ( 95–100%, n   100) at 25 C
(Fig. 1 G). The actin clumps disappeared rapidly in re-
sponse to the actin monomer sequestering drug latrunculin-
A (Ayscough et al., 1997; unpublished data), suggesting
that actin turnover is not severely affected by Prk1p inhibi-
tion. In total, these data support the possibility that actin
clumps are the result of unregulated Arp2/3-stimulated ac-
tin assembly.
Real-time analysis of actin patch dynamics 
upon Prk1p inhibition
To investigate actin patch dynamics as a function of Prk1p
inhibition, we performed real-time analyses of ark1  prk1-
as1 cells expressing Abp1-GFP (Fig. 2). Similar results were
obtained with ark1   prk1-as3 cells (unpublished data).
Abp1p is a component of cortical actin patches (Drubin et
al., 1988). Within 1 to 2 min of 1NA-PP1 addition to
ark1   prk1-as1 cells, Abp1-GFP patches aggregated into
clumps (Fig. 2 A and Video 1, available at http://
www.jcb.org/cgi/content/full/jcb.200305077/DC1). Once
formed in the daughter cell, the actin clumps invariably
moved toward the bud neck, and then into the mother cell
(Fig. 2 B), consistent with the observation for fixed cells
(Fig. 1 F), which exhibited an increase of mother clumps
and a decrease of daughter clumps during the time course.
The mechanistic basis for this movement is unknown, but
does not seem to involve microtubules because the process
was not sensitive to the microtubule-depolymerizing drug
nocodazole (unpublished data). Within 1 min of Prk1p re-
activation by inhibitor washout, the clumps disassembled,
and the normal polarized distribution of Abp1 patches wasT
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
Chemical genetics of Prk1p | Sekiya-Kawasaki et al. 767
Figure 1. Initial characterization of ark1  prk1-as mutants. (A) To observe the actin morphology, cells were stained with rhodamine-phalloidin. 
The range of actin morphologies of ark1  prk1-as3 cells treated with 1NA-PP1 for 2 min is shown. A mock-treated cell is also shown. (B) Actin 
morphology of small-budded ark1  prk1-as1 (AS1) and ark1  prk1-as3 (AS3) cells was scored as a function of 1NA-PP1 concentration in a 
blind study (n   200 for each sample). The cells were treated with the inhibitor for 1 h before fixation. (C and D) ark1  PRK1 (WT), ark1  
prk1-as1, and ark1  prk1-as3 cells were cultured without 1NA-PP1 (C), or with the indicated concentration of 1NA-PP1 for 30 min (D), and 
then processed for anti-Ent1p Western blotting. (E) Ent1 phosphorylation as a function of time in ark1  prk1-as1 cells treated with 80  M 
1NA-PP1. (C–E) Phosphorylated (Ent1-P) and unphosphorylated (Ent1) forms of Ent1p are indicated. (F) Actin morphology of small-budded 
ark1  prk1-as3 cells in the presence of 40  M 1NA-PP1 at indicated time points (n  100). (G) Actin morphology of ark1  prk1-as3
and ark1  prk1-as3 arp2–1. The cells were mock treated or treated with 1NA-PP1 at 25 C for 15 min before fixation. Strains: ark1  PRK1, 
DDY2547; ark1  prk1-as1, DDY2595; ark1  prk1-as3, DDY2597; ark1  prk1-as3 arp2–1, DDY2610. Bars, 5  m.T
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restored (Fig. 2 C and Video 2). Rhodamine-phalloidin
staining of fixed ark1  prk1-as1 cells confirmed that F-actin
undergoes reversible aggregation upon 1NA-PP1 addition
(unpublished data).
The endocytic proteins Sla2p, Pan1p, Sla1p, and Ent1p,
which localize at actin patches in wild-type cells, were pre-
viously shown to be present in the large actin clumps in
ark1  prk1  cells (Cope et al., 1999; Watson et al., 2001;
Warren et al., 2002). We found that all of these proteins
are also present in the inhibitor-induced clumps (Fig. 2
D for Sla2p; unpublished data for Pan1p, Sla1p, and
Ent1p). The rapid and reversible actin clump formation
described in Figs. 1 and 2 revealed that the wild-type actin
patches are under tight regulation by protein phosphory-
lation. Several lines of evidence support the conclusion
that actin clump formation is a direct consequence of
inhibiting phosphorylation of actin patch components.
First, all known in vivo targets (Pan1p, Sla1p, and Ent1p)
of Prk1p are actin patch proteins. Second, Prk1p kinase is
exclusively localized in cortical actin patches (Cope et al.,
1999; Zeng and Cai, 1999). Third, actin clumps form
rapidly upon addition of 1NA-PP1, and disappear rapidly
when it is removed.
Receptor-mediated endocytic internalization is 
blocked upon Prk1p inhibition
Further, we tested whether Prk1p kinase activity is required
for  -factor internalization by its receptor, Ste2p. Because of
its high sensitivity to 1NA-PP1, all subsequent analyses used
the prk1-as3 allele. Without inhibitor, ark1  prk1-as3 cells
show internalization kinetics indistinguishable from ark1 
PRK1 (Fig. 3 A). Treatment of ark1  prk1-as3 cells with
1NA-PP1 for 30 min specifically inhibited receptor internal-
ization (Fig. 3 B). Even 120  M inhibitor did not affect
 -factor internalization by ark1  PRK1 cells (Fig. 3 B).
Additionally, a kinase-dead mutant (ark1  prk1
D159A) also
showed a severe block of receptor internalization (Fig. 3 C).
Thus, the inhibition of Prk1p kinase activity profoundly
blocks the internalization step of receptor-mediated endocy-
tosis.
Association of endocytic membranes with actin upon 
Prk1p inhibition
Next, we investigated the fate of the endocytic membrane
marker FM4-64 (Vida and Emr, 1995) in inhibitor-treated
ark1  prk1-as3 cells (Fig. 4). FM4-64 was first incorporated
Figure 2. Reversible actin clump formation from 
cortical actin patches upon inhibition of Prk1p 
activity. A and C are the selected frames from 
Video 1 and Video 2, respectively. (A–C) ark1  
prk1-as1 cells expressing Abp1-GFP were imaged. 
(A and B) Cells before or after treatment with 
1NA-PP1 for the indicated times. (A) The two Abp1 
patches (top, arrowheads) or already formed clumps 
(bottom, arrowheads) fuse to become one entity 
(asterisks) upon addition of 1NA-PP1. (B) An Abp1 
clump (arrowhead) moves from the daughter to the 
mother cell. (C) Cells were pretreated with 1NA-PP1 
for 30 min, followed by washout of the inhibitor. 
An Abp1 clump at the neck (arrowhead) disappears 
during the time course. (D) ark1  prk1-as1 cells 
expressing Abp1-CFP (red) and Sla2-YFP (green) 
were imaged after a 10-min treatment with 1NA-PP1. 
Mock-treated cells are also shown. The actin 
clumps are marked with arrowheads. Exposure 
times for each panel: 1 s for A and C, 66 ms for B, 
and 300–700 ms for D. Strains: ark1  prk1-as1 
ABP1-GFP, DDY2600 (A and C) and DDY2601 
(B); ark1  prk1-as1 ABP1-CFP SLA2-YFP, 
DDY2603 (D). Bars, 5  m.T
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into the plasma membrane (Fig. 4 A, 0 min). In mock-
treated ark1  prk1-as3 or wild-type cells, this dye is later
found in endosomes (Fig. 4 A, top, 5 min) and finally accu-
mulates in vacuoles (Vida and Emr, 1995; unpublished
data). In mock-treated cells, the endosomes seen at 5 min do
not show significant colocalization with Abp1p (Fig. 4 A,
top). Next, we treated ark1  prk1-as3 cells simultaneously
with FM4-64 and 1NA-PP1. At 5 min, we found that FM4-
64 staining colocalized with actin clumps (Fig. 4 A, bot-
tom). The FM4-64 dye in actin clumps was later trans-
ported to vacuoles (after 15–20 min), although the kinetics
were delayed compared with the wild type (10 min; unpub-
lished data). These observations suggest that the block of
Prk1p activity leads to accumulation of an endocytic com-
partment that associates with actin.
Next, we examined ark1  prk1  (Fig. 4, C–H and K–N)
and inhibitor-treated ark1  prk1-as3 cells (Fig.4, I and J for
cells treated for 10 min; also see Fig. S1) by conventional
EM. To better visualize actin filaments, we first observed
cells post-treated with tannic acid (Fig. 4, B–J). Compared
with wild-type cells that showed no remarkable morphology
(Fig. 4 B), both ark1  prk1  and inhibitor-treated ark1 
prk1-as3 cells showed clustered vesicles of  100 nm (ar-
rows) in the area where microfilaments (arrowheads) are ob-
served (Fig. 4, C–J, dashed area; also see Fig. S1). Next, we
observed ark1  prk1  cells processed by high pressure freez-
ing followed by freeze substitution, and also detected accu-
mulation of  100-nm vesicles (Fig. 4, K–N, arrows). With
this procedure, the vesicles are seen within areas that exclude
ribosomes (Fig. 4 K, dashed area), and they sometimes ap-
pear to have electron-dense coats (Fig. 4 M, left arrow; Fig.
4 N, arrow). The colocalization of vesicles with microfila-
ments and ribosome exclusion areas suggested that the vesi-
cles might reside within actin clumps. Therefore, we used
immuno-EM to determine if this was indeed the case (Fig.
4, O–R). In indirect immunolabeling for actin on ultrathin
cryosections of fixed ark1  prk1  cells, 10-nm gold parti-
cles were seen to localize to slightly electron-dense areas (Fig.
4 O, dashed area). These immunogold-labeled actin clumps
were seen to contain  100-nm vesicles similar to those seen
using conventional EM (Fig. 4, O–Q, dashed boxes). Thus,
we conclude that the block of the Ark kinases leads to the ac-
cumulation of actin and actin-associated vesicles. Addition-
ally, in double-immunogold labeling for Sla1-GFP (5-nm
gold) and actin (10-nm gold), Sla1-containing vesicles were
occasionally detected within the actin clumps (Fig. 4 R).
In this work, we examined the rapid and acute effects of
Prk1p kinase inhibition and reactivation by applying a
chemical genetics approach. We showed that abnormal actin
clumps formed and disappeared within 1 to 2 min of Prk1p
inhibition and reactivation, respectively. Further, we showed
that the actin clumps contain endocytic proteins and  100-
nm vesicles. We propose that Prk1p directly regulates the
coupling between actin assembly and endocytosis by pro-
moting disassembly and/or inactivation of an early endocytic
complex that stimulates actin assembly (Fig. 5 A). When
Prk1p is inhibited, this complex is stabilized, and actin as-
sembly continues to be stimulated by endocytic proteins
such as the Prk1p target Pan1p and the associated Arp2/3
complex (Zeng and Cai, 1999; Duncan et al., 2001), and/or
other targets including Sla1p and Ent1p (Watson et al.,
2001; Zeng et al., 2001; Fig. 5 B). In mammalian cells, the
 2 subunit of AP2 is phosphorylated by AAK1 at Thr-156
(ITSQVT
156G) (Ricotta et al., 2002). However, the bud-
ding yeast AP2 homologue, Apm4p (Huang et al., 1999), is
not important for receptor internalization and does not con-
tain potential Prk1p-phosphorylation motifs similar to
(L/IxxQxTG). Rather, our genetic experiment showing that
Arp2p is required for clump formation supports the idea
that Arp2/3-mediated actin assembly is negatively regulated
by Prk1p, potentially via phosphorylation of the Arp2/3 ac-
Figure 3. Defective receptor-mediated endocytosis upon inhibition 
of Prk1p activity. Internalization of 
35S-labeled  -factor was measured. 
In A and B, the time course of internalization was started after 30 
min incubation with 1NA-PP1 or mock treatment. (A) ark1  PRK1 
(WT) and ark1  prk1-as3 (AS3) cells without 1NA-PP1. (B) ark1  
PRK1 (WT) and ark1  prk1-as3 (AS3) cells treated with 1NA-PP1. 
(C) ark1  PRK1(WT) and ark1  prk1
D159A cells. Error bars represent 
the SD from at least three experiments. The experiment with ark1  
PRK1 in B was performed twice. Strains: ark1  PRK1, DDY2607; 
ark1  prk1-as3, DDY2608; ark1  prk1
D159A, DDY2609.T
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was introduced 249 bp upstream of the PRK1 ORF. The mutated KpnI/
SacI PRK1 fragment was cloned into pBlueScript
® II SK, and the PRK1
fragment was marked with URA3 at NotI to create a plasmid pDD877.
prk1-as1 (M108G), prk1-as3 (M108G, C175A), and prk1
D159A mutations
were created in pDD877. The URA3-marked, PRK1-containing fragments
were excised from the integration plasmids, and replaced the prk1 ::
LEU2 locus. These strains were each crossed with an ark1  strain, and the
diploids were sporulated to obtain ark1  prk1 mutants. Analogue-sensi-
tive Prk1 mutant proteins were expressed at normal levels, but Prk1
D159Ap
was expressed at only 20–30% of normal levels at 25 C. The gene dele-
tions were created as described previously (Cope et al., 1999). Functional
GFP and CFP tags were integrated at the COOH terminus of Abp1p and
Sla1p as described previously (Warren et al., 2002). To create Sla2-YFP,
five alanines were introduced at the junction between the SLA2 ORF and
YFP using pDH5 (from the Yeast Resource Center, Seattle, WA). The Sla2-
YFP strain has growth properties that are indistinguishable from the wild
type. pDD890 expresses Abp1-GFP from pRB2139 (Doyle and Botstein,
1996) on pRS317.
Figure 4. Actin-associated membrane 
accumulation upon inhibition of Prk1p 
activity. (A) FM4-64 labeling of ark1  
prk1-as3 cells expressing Abp1-GFP. 
Cells were treated with media containing 
FM4-64 and 1NA-PP1 in a flow chamber. 
FM4-64 (red) and Abp1-GFP (green) 
were visualized at 0 and 5 min. Mock-
treated cells are also shown. (B–J) Con-
ventional EM of cells post-treated with 
1% tannic acid. (B) A wild-type cell 
shows normal, unremarkable morphology. 
(C–H) ark1  prk1  cells reveal electron-
dense areas (encircled by dashed line 
in C) containing a heterogeneous popu-
lation of  100-nm vesicles (shown at 
higher magnification in D and indicated 
by arrows in C and D), as well as numer-
ous microfilament profiles (marked by 
arrowheads in D–H). (I and J) ark1  
prk1-as3 cells treated with 1NA-PP1 for 
10 min also reveal  100-nm vesicles 
and microfilament profiles (marked by 
arrowheads). For more examples, also 
see Fig. S1. (K–N) EM of cells fixed 
by high pressure freezing and freeze 
substitution. ark1  prk1  cells reveal 
ribosome exclusion areas (encircled by 
dashed line in K) containing  100-nm 
vesicles (some of which are indicated by 
arrows in K–N). Ribosomes appear as 
small, uniform, electron-dense spots 
distributed throughout most of the cyto-
plasm. (O–Q) Indirect immunogold la-
beling of ultrathin cryosections of ark1  
prk1  cells demonstrates the localization 
of actin within a slightly electron-dense/
vesicle-enriched region (encircled by 
dashed line in O). In many instances, 
vesicles/membranous elements are 
detected within actin-labeled region 
(arrows in O and Q; boxed areas P and Q). 
(R) Double-indirect immunogold labeling 
with ark1  prk1  SLA1-GFP cells reveals 
occasional Sla1p-containing vesicles 
(5-nm gold, arrowheads) amid a clus-
tered/electron-dense actin region 
(10-nm gold). Strains: ark1  prk1-as3 
ABP1-GFP, DDY2606 (A); Wild-type, 
DDY904 (B); ark1  prk1 , DDY2541 
(C–H and O–Q) and DDY1564 (K–N); ark1  prk1-as3, DDY2597 (I and J); ark1  prk1  SLA1-GFP, DDY2611 (R). n, nucleus; V, vacuole; 
pm, plasma membrane. Bars: (A) 5  m; (B) 1  m; (C) 0.2  m; (D) 0.5  m; (E–J) 0.1  m; (K) 0.5  m; (L–R) 0.1  m.
tivator, Pan1p. Our data also support the proposal that actin
participates directly in yeast endocytosis.
Materials and methods
Media, growth conditions, and materials
Yeast strains were grown in standard rich media (YPD) or synthetic media
(SD) supplemented with the appropriate amino acids. 1NA-PP1was syn-
thesized and handled as described previously (Bishop et al., 1998). ark1 
prk1-as1 cells were treated with 80  M inhibitor and ark1  prk1-as3 cells
with 40  M inhibitor in SD-based media unless indicated otherwise. All
the yeast strains were cultured at 25 C, except for DDY904 and ark1 
prk1 , which were cultured at 30 C.
Strains and plasmids
The yeast strains are listed in Table I. prk1 ::PRK1::URA3 and prk1 ::
prk1::URA3 integration plasmids were created as follows: First, a NotI siteT
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Fluorescent microscopy
F-actin was stained as described previously (Cope et al., 1999). FM4-64
was used at a concentration of 8  M in SD-based media. For live imaging,
cells were attached to 50  g/ml concanavalin A–coated long coverslips
(24   50 mm). A flow chamber was made by mounting a small coverslip
(18   18 mm) on top of the long coverslip with grease and small pieces of
coverslips as spacers. Two sides were left unsealed so that media could be
exchanged. Cells were viewed using a microscope (model TE300; Nikon)
equipped with a 100  objective, NA 1.4, and a cooled CCD camera
(Hamamatsu). Phase-3 software (Phase-3 Imaging Systems) was used for vi-
sualization of rhodamine, GFP, and FM4-64. In a CFP–YFP colocalization
study, cells were photographed by rapidly alternating excitation/emission
filters (JP4 filter sets; Chroma Technology Corp.). Filter wheels (Lambda
10–2; Sutter Instrument Co.) were mounted on the excitation and emission
ports of the microscope and were controlled with MetaMorph
® software
(Universal Imaging Corp.).
Electron microscopy
Morphological observations of cells by conventional EM was performed
essentially as described previously (Rieder et al., 1996), except that after
fixation with FeCNOsO4/thiocarbohydrazide/FeCNOsO4 (OTO), the cells
were further treated with 1% tannic acid for 30 min. Morphological obser-
vations of cells fixed by high pressure freezing and freeze substitution were
performed as described in McDonald and Müller-Reichert (2002). Im-
muno-EM was performed as described previously (Rieder et al., 1996). Pri-
mary antibodies used were affinity-purified rabbit anti-actin antibody (a
gift from A. Bretscher, Cornell University, Ithaca, NY) and mouse anti-GFP
antibody (StressGen Biotechnologies); secondary 5- and 10-nm gold con-
jugates were obtained from Jackson Immunoresearch Laboratories.
Protein and immunological techniques
To obtain yeast whole-cell lysates, the cells were lysed with glass beads in
ice-cold lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40,
protease inhibitor cocktail, 50 mM NaF, 0.2 mM sodium orthovanadate,
25 mM  -glycerophosphate, 1  M cyclosporin A, 4and 0  M cantharidin).
50  g of the lysate was loaded per lane. For the time-course experiment,
2-OD cells were harvested and resuspended in 50  l lysis buffer (50 mM
Tris, pH 6.8, 2% SDS, 100 mM DTT, 8% glycerol, 0.02% BPB, protease
inhibitor cocktail, 50 mM NaF, 0.2 mM sodium orthovanadate, 25 mM
 -glycerophosphate, and 1  M cyclosporin A). The suspension was boiled
for 3 min, and then lysed with glass beads for 2 min, followed by 1 min of
boiling. 100  l of the SDS-PAGE buffer was finally added to the lysate. 10
Table I. Yeast strains
Strain Genotype Source
DDY426 MATa/MAT  his3- 200/his3- 200 leu2-3, 112/leu2-3, 112 ura3-52/ura3-52 ade2-1/
ADE2 lys2-801/lys2-801
Drubin lab
DDY904
b MAT  his3- 200 leu2-3, 112 ura3-52 lys2-801 Drubin lab
DDY1102 MATa/MATa his3- 200/his3- 200 leu2-3, 112/leu2-3, 112 ura3-52/ura3-52 ade2-1/
ADE2 lys2-801/LYS2
Drubin lab
DDY1564
a MATa his3- 200 leu2-3, 112 ura3-52 lys2-801 ark1 ::HIS3 prk1 ::LEU2 Drubin lab
DDY2541
b MATa his3- 200 leu2-3, 112 ura3-52 lys2-801 ark1 ::cgHIS3
c prk1 ::cgLEU2
c This work
DDY2547
b MATa his3- 200 leu2-3, 112 ura3-52 lys2-801 ark1 ::cgHIS3
c prk1 ::PRK1::URA3 This work
DDY2595
b MATa his3- 200 leu2-3, 112 ura3-52 lys2-801 ark1 ::cgHIS3
c prk1 ::prk1-as1::URA3 This work
DDY2597
b MATa his3- 200 leu2-3, 112 ura3-52 lys2-801 ark1 ::cgHIS3
c prk1 ::prk1-as3::URA3 This work
DDY2600
a MAT  his3- 200 ura3-52 leu2-3, 112 lys2-801 ark1 ::LEU2 prk1 ::prk1-as1::URA3 
ABP1-GFP::HIS3
This work
DDY2601
a MATa his3- 200 ura3-52 leu2-3, 112 lys2-801 ark1 ::LEU2 prk1 ::prk1-as1::URA3 with 
pDD890 [CEN, LYS2, ABP1-GFP]
This work
DDY2603
a MATa his3- 200 ura3-52 leu2-3, 112 lys2-801 ark1 ::LEU2 prk1 ::prk1-as1::URA3 
ABP1-CFP::KanMX6 SLA2-YFP::HIS3
This work
DDY2606
b MATa his3- 200 ura3-52 leu2-3, 112 lys2-801 ark1 ::cgHIS3
c prk1 ::prk1-as3::URA3 
ABP1-GFP::HIS3
This work
DDY2607
a MATa his3- 200 ura3-52 leu2-3, 112 lys2-801 ark1 ::HIS3 prk1 ::PRK1::URA3 bar1 ::
cgLEU2
c
This work
DDY2608
a MATa his3- 200 ura3-52 leu2-3, 112 lys2-801 ark1 ::HIS3 prk1 ::prk1-as3::URA3 
bar1 ::cgLEU2
c
This work
DDY2609
a MATa his3- 200 ura3-52 leu2-3, 112 lys2-801 ark1 ::HIS3 prk1 ::prk1
D159A::URA3 
bar1 ::cgLEU2
c
This work
DDY2610
b MATa his3- 200 leu2-3, 112 ura3-52 lys2-801 ark1 ::cgHIS3
c prk1 ::prk1-as3::URA3 
arp2-1::URA3
d
This work
DDY2611
b MATa his3- 200 leu2-3, 112 ura3-52 lys2-801 ark1 ::cgHIS3
c prk1 ::cgLEU2
c SLA1-
GFP::HIS3
This work
aDerived from DDY426.
bDerived from DDY1102.
ccgHIS3 and cgLEU2 indicate Candida glabrata HIS3 and LEU2 genes, respectively.
darp2-1 allele (Moreau et al., 1997) was crossed into our strain background.
Figure 5. Model for Ark-kinase function in endocytosis. (A) In 
wild-type cells, Prk1p promotes proper disassembly of the actin-
associated endocytic complex. Phosphatase(s) might be responsible 
for reformation and/or activation of the endocytic complex. Ark1p, 
a closely related homologue of Prk1p, is likely to perform an over-
lapping function. (B) When Ark1p and Prk1p are inhibited, vesicles 
associated with actin filaments and endocytic proteins accumulate. 
See text for further discussion.T
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 l of the final supernatant was loaded per lane. Anti-Ent1p antibody (Wat-
son et al., 2001) was used at 1:10,000 dilution for Western blotting.
 -factor uptake assay
35S-labeled  -factor was prepared as described in Howard et al. (2002).
The  -factor uptake assay was performed at 25 C based on a continuous
incubation protocol (Dulic et al., 1991) with modifications as follows: cells
were grown in SD, harvested by centrifugation, and resuspended in inter-
nalization media (SD media with 0.5% casamino acid and 1% BSA). Then
the cells were mixed with an equal volume of SD media containing 2 
concentration of 1NA-PP1. After incubation with 1NA-PP1 for 30 min,
30,000 cpm/100  l 
35S-labeled  -factor was added at time zero. At the in-
dicated time points, aliquots were withdrawn and diluted in ice-cold
buffer at pH 6.0 (total  -factor) or pH 1.1 (internalized  -factor). The sam-
ples were then filtered, and radioactivity was measured in a scintillation
counter. The results were expressed as the ratio of pH 1.1 cpm/pH 6.0 cpm
for each time point to represent the percentage of internalization.
Online supplemental material
Video 1 and Video 2 show ark1  prk1-as1 cells expressing Abp1-GFP. The
representative frames of the movies are shown in Fig. 2 A and Fig. 2 C. Fig.
S1 shows EM of ark1  prk1-as3 cells post-treated with tannic acid. Online
supplemental material available at http://www.jcb.org/cgi/content/full/
jcb.200305077/DC1.
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